Company Filing History:
Years Active: 1990
Title: Niels Fiil: Innovator in Biosynthetic Insulin Precursors
Introduction
Niels Fiil is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of biosynthetic insulin precursors. His work has implications for diabetes treatment and insulin production.
Latest Patents
Niels Fiil holds a patent for a DNA-sequence encoding biosynthetic insulin precursors. This patent describes a process for creating human insulin precursors that contain the peptide chain B(1-29)-A(1-21) of human insulin. The method involves culturing a yeast host that has been transformed with an expression vehicle capable of expressing the DNA-sequence encoding the insulin precursor. The bridging chain in the insulin precursor is designed to be relatively short, containing between 2 to 8 amino acid residues, and must not include two adjacent basic amino acid residues.
Career Highlights
Niels Fiil has worked at Novo Industri A/S, a leading company in the biotechnology sector. His innovative approach to insulin production has positioned him as a key figure in the field. His patent reflects his commitment to advancing medical science and improving patient outcomes.
Collaborations
Niels has collaborated with notable colleagues such as Jan Markussen and Mogens T Hansen. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Niels Fiil's work in biosynthetic insulin precursors showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are vital in the ongoing efforts to enhance diabetes treatment through advanced biotechnology.